In 2011, Yasui et al. demonstrated the in vivo inhibition effect of this compound on the expression of tumor necrosis factor (TNFα), nuclear factor kappa B (NF-κB) and interleukin 1β (IL-1β), as well as some inflammatory cytokines that play an important role in tumor promotion [101]. This evidence concerns the gene NFKB1 and neoplasm.